Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-01-16 @ 10:04 AM
Study NCT ID:
NCT04687020
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-10-19
First Post:
2020-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
Sponsor:
NS Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VILT-502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None